Nonresponse to pre-operative chemotherapy does not preclude long-term survival after liver resection in patients with colorectal liver metastases.

作者: Ulf P. Neumann , Armin Thelen , Christoph Röcken , Daniel Seehofer , Marcus Bahra

DOI: 10.1016/J.SURG.2009.02.004

关键词: HepatectomyMultivariate analysisInternal medicineCancerColorectal cancerIn patientMedicineCarcinoembryonic antigenTumor progressionChemotherapyGastroenterology

摘要: Background Liver resection is the only curative treatment offering a chance of long-term survival in patients with colorectal liver metastases (CRM). Recent data indicated that tumor progression while receiving chemotherapy was associated poor outcome. The aim study to identify risk factors for outcome pre-operative CRM. Methods We analyzed 160 after CRM preoperative systemic. chemotherapy. Three groups were identified: 44 (27.5%) had response, 20 (12.5%) showed stable disease, and 96 (60%) on Median follow-up 2.4 years (range, 6 days–11.1 years). All available clinicopathologic variables possibly evaluated. Results Survival 88%, 53%, 37% at 1, 3, 5 years. Noncurative resection, carcinoembryonic antigen levels >200 ng/ml, grading, size largest >5 cm, number patient In multivariate analysis, free margin grading correlated Tumor no influence survival. Conclusion offers benefit CRM, even when growth proceeds during

参考文章(37)
Reńe Adam, Henri Bismuth, Denis Castaing, Fabio Waechter, Francisco Navarro, Alvaro Abascal, Pietro Majno, Luc Engerran, Repeat hepatectomy for colorectal liver metastases. Annals of Surgery. ,vol. 225, pp. 51- 62 ,(1997) , 10.1097/00000658-199701000-00006
George M. Fuhrman, Steven A. Curley, David C. Hohn, Mark S. Roh, Improved survival after resection of colorectal liver metastases Annals of Surgical Oncology. ,vol. 2, pp. 537- 541 ,(1995) , 10.1007/BF02307088
Bernard Nordlinger, Marguerite Guiguet, Jean-Christophe Vaillant, Pierre Balladur, Karim Boudjema, Philippe Bachellier, Daniel Jaeck, Association Française de Chirurgie, Surgical resection of colorectal carcinoma metastases to the liver: A prognostic scoring system to improve case selection, based on 1568 patients Cancer. ,vol. 77, pp. 1254- 1262 ,(1996) , 10.1002/(SICI)1097-0142(19960401)77:7<1254::AID-CNCR5>3.0.CO;2-I
J Scheele, Resection of colorectal liver metastases revisited. Journal of Gastrointestinal Surgery. ,vol. 1, pp. 408- 422 ,(1997) , 10.1016/S1091-255X(97)80127-8
Reid B. Adams, Bernard Langer, Resection Margins for Colorectal Metastases to The Liver: Do They Make A Difference? Hpb Surgery. ,vol. 9, pp. 115- 117 ,(1996) , 10.1155/1996/95180
S. Jonas, A. Thelen, C. Benckert, A. Spinelli, S. Sammain, U. Neumann, B. Rudolph, P. Neuhaus, Extended Resections of Liver Metastases from Colorectal Cancer World Journal of Surgery. ,vol. 31, pp. 511- 521 ,(2007) , 10.1007/S00268-006-0140-3
J. C. Hewes, S. Dighe, R. W. Morris, R. R. Hutchins, S. Bhattacharya, B. R. Davidson, Preoperative Chemotherapy and the Outcome of Liver Resection for Colorectal Metastases World Journal of Surgery. ,vol. 31, pp. 353- 364 ,(2007) , 10.1007/S00268-006-0103-8
Y. Fong, Surgical therapy of hepatic colorectal metastasis. CA: A Cancer Journal for Clinicians. ,vol. 49, pp. 231- 255 ,(1999) , 10.3322/CANJCLIN.49.4.231
Felix G. Fernandez, Jeffrey A. Drebin, David C. Linehan, Farrokh Dehdashti, Barry A. Siegel, Steven M. Strasberg, Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET). Annals of Surgery. ,vol. 240, pp. 438- 450 ,(2004) , 10.1097/01.SLA.0000138076.72547.B1
Henry Bismuth, René Adam, Françis Lévi, Christian Farabos, Fabio Waechter, Denis Castaing, Pietro Majno, Luc Engerran, Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Annals of Surgery. ,vol. 224, pp. 509- 522 ,(1996) , 10.1097/00000658-199610000-00009